Literature DB >> 30140627

Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein.

Ying-Chih Wang1, Xuan Yang1, Wen-Bin Wei1, Xiao-Lin Xu1.   

Abstract

AIM: To reveal the insight mechanism of liver metastasis in uveal melanoma, we investigated cell functions of microRNA-21 in three different uveal melanoma cell lines and analyze the relationship of target gene p53 and its downstream targets.
METHODS: Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect microRNA-21 expression in normal uveal tissue and uveal melanoma cell lines. Lenti-virus expression system was used to construct OCM-1, MuM-2B and M619 cell line with stable overexpression and inhibition of microRNA-21. In vitro cell function tests such as cell proliferation, cell apoptosis, cell circle and abilities of migration and invasion were examined by MTT, BrdU assay, flow cytometry, transwell assay and Matrigel invasion assay respectively. The target gene was predicted by bioinformatics and confirmed by using a dual luciferase reporter assay. The expression of p53 and its suspected downstream targets LIM and SH3 protein 1 (LASP1) and glutathione S transferase pi (GST-Pi) were determined by qRT-PCR in mRNA level and Western blotting analysis in protein level. Finally, the effect of microRNA-21 in a xenograft tumor model was assessed in four-week-old BALB/c nude mice.
RESULTS: Compared to normal uveal melanoma, expressions of microRNA-21 were significantly higher in uveal melanoma cell lines. Overexpression of microRNA-21 promoted proliferation, migration, and invasion of OCM-1, M619 and MuM-2B cells, while inhibition of microRNA-21 reveal opposite effects. Wild type p53 was identified as a target gene of microRNA-21-3p, and proved by dual luciferase reporter assay. Up-regulated microRNA-21 inhibited the expression of wild type p53 gene, and the increased expression of LASP1 in mRNA level and protein level, while down-regulated microRNA-21 presented opposite way. However, GST-pi showed the potential pattern as expected, but relative mRNA level showed no statistically significant difference in OCM-1 cells. Furthermore, the mRNA expression of GST-pi was decreased in microRNA-21 overexpressing MuM-2B, and increased in M619 cells with inhibition of microRNA-21. In vivo, inhibition of microRNA-21 reduced tumor growth with statistically significant difference.
CONCLUSION: These findings provide novel insight into molecular etiology of microRNA-21 in uveal melanoma cell lines, and suggest that microRNA-21 might be a potential candidate for the diagnosis and prognostic factor of human uveal melanoma.

Entities:  

Keywords:  Glutathione S Transferase pi; LIM and SH3 protein 1; microRNA-21; p53; uveal melanoma

Year:  2018        PMID: 30140627      PMCID: PMC6090126          DOI: 10.18240/ijo.2018.08.03

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  43 in total

1.  Amitriptyline may have a supportive role in cancer treatment by inhibiting glutathione S-transferase pi (GST-π) and alpha (GST-α).

Authors:  Gulnihal Kulaksiz-Erkmen; Ozlem Dalmizrak; Gamze Dincsoy-Tuna; Arın Dogan; I Hamdi Ogus; Nazmi Ozer
Journal:  J Enzyme Inhib Med Chem       Date:  2011-12-07       Impact factor: 5.051

2.  Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.

Authors:  Yaguang Xi; Reut Shalgi; Oystein Fodstad; Yitzhak Pilpel; Jingfang Ju
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

3.  MicroRNAs are significantly influenced by p53 and radiation in HCT116 human colon carcinoma cells.

Authors:  Sangsu Shin; Hwa Jun Cha; Eun-Mee Lee; Jin Hyuk Jung; Su-Jae Lee; In-Chul Park; Young-Woo Jin; Sungkwan An
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

4.  Prognostic value of circulating microRNA-21 in digestive system cancers: a meta-analysis.

Authors:  Ting-Ting Ye; Yin-Long Yang; Xin-Ying Liu; Qian-Qing Ji; Yi-Fei Pan; You-Qun Xiang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

5.  Redefining the p53 response element.

Authors:  Bei Wang; Ziwei Xiao; Ee Chee Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-13       Impact factor: 11.205

Review 6.  The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.

Authors:  F Xu; L Xu; M Wang; G An; G Feng
Journal:  Colorectal Dis       Date:  2015-05       Impact factor: 3.788

7.  The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab.

Authors:  Kojiro Eto; Masaaki Iwatsuki; Masayuki Watanabe; Satoshi Ida; Takatsugu Ishimoto; Shiro Iwagami; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2013-10-24       Impact factor: 5.344

8.  Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions.

Authors:  V Schreiber; C Moog-Lutz; C H Régnier; M P Chenard; H Boeuf; J L Vonesch; C Tomasetto; M C Rio
Journal:  Mol Med       Date:  1998-10       Impact factor: 6.354

9.  MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

Authors:  Shuomin Zhu; Min-Liang Si; Hailong Wu; Yin-Yuan Mo
Journal:  J Biol Chem       Date:  2007-03-15       Impact factor: 5.157

10.  Glutathione S-transferases in liver metastases of colorectal cancer. A comparison with normal liver and primary carcinomas.

Authors:  T P Mulder; H M Roelofs; W H Peters; M J Wagenmans; C F Sier; H W Verspaget
Journal:  Carcinogenesis       Date:  1994-10       Impact factor: 4.944

View more
  10 in total

Review 1.  Emerging roles of microRNAs and their implications in uveal melanoma.

Authors:  Chun Yang; Yuejiao Wang; Pierre Hardy
Journal:  Cell Mol Life Sci       Date:  2020-08-11       Impact factor: 9.261

2.  Parthenolide inhibits the proliferation and induces the apoptosis of human uveal melanoma cells.

Authors:  Song-Tian Che; Li Bie; Xu Li; Hui Qi; Peng Yu; Ling Zuo
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

Review 3.  Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma.

Authors:  Daniël P de Bruyn; Aaron B Beasley; Robert M Verdijk; Natasha M van Poppelen; Dion Paridaens; Ronald O B de Keizer; Nicole C Naus; Elin S Gray; Annelies de Klein; Erwin Brosens; Emine Kiliç
Journal:  Biomedicines       Date:  2022-02-21

Review 4.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

5.  MiR-9-5p Inhibits the Proliferation, Migration and Invasion of Choroidal Melanoma by Targeting BRAF.

Authors:  Manman Ying; Hao Feng; Xiaonan Zhang; Ran Liu; Hong Ning
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

6.  Current molecular and clinical insights into uveal melanoma (Review).

Authors:  Matteo Fallico; Giuseppina Raciti; Antonio Longo; Michele Reibaldi; Vincenza Bonfiglio; Andrea Russo; Rosario Caltabiano; Giuseppe Gattuso; Luca Falzone; Teresio Avitabile
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

Review 7.  Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis.

Authors:  Carla Enrica Gallenga; Elena Franco; Ginevra Giovanna Adamo; Sara Silvia Violanti; Paolo Tassinari; Mauro Tognon; Paolo Perri
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

8.  Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma.

Authors:  Wen-Da Zhou; Lei Shao; Li Dong; Rui-Heng Zhang; Yi-Fan Li; He-Yan Li; Hao-Tian Wu; Xu-Han Shi; Wen-Bin Wei
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

9.  JMJD2C mediates the MDM2/p53/IL5RA axis to promote CDDP resistance in uveal melanoma.

Authors:  Qi Zhu; Han Chen; Xiaoying Li; Xi Wang; Hongtao Yan
Journal:  Cell Death Discov       Date:  2022-04-25

Review 10.  Update on uveal melanoma: Translational research from biology to clinical practice (Review).

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Natalio García-Honduvilla; Santiago Coca; Melchor Álvarez-Mon; Julia Buján; Miguel A Teus
Journal:  Int J Oncol       Date:  2020-10-22       Impact factor: 5.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.